Oppositional Defiant Disorder | Defiant Teenager | Defiant Kid | ADHD

Back to ADHD News List

FDA Issues Approvable Letter For SPD465 Triple Bead Mixed Amphetamine Salts For The Treatment Of ADHD In Adults

Shire plc (LSE: SHP; Nasdaq: SHPGY; TSX: SHQ) announced today that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) for SPD465 (triple-bead mixed amphetamine salts [MAS], an investigational oral stimulant intended to provide symptom control of ADHD in adults for up to 16 hours with one daily dose. Following receipt of this approvable letter, Shire is evaluating its options related to SPD465. [click link for full article]

Source: http://www.medicalnewstoday.com/sections/adhd/

In schools, treatment plans are often poorly integrated. In addition, there are few special education funds directed specifically for ADHD
 

This page is about Attention deficit hyperactivity disorder (ADHD)